mHealth Intelligence October 9, 2023
With the extension, healthcare providers can prescribe controlled substances, including Adderall and Vicodin, through telehealth without a prior in-person exam.
In the face of unflagging resistance from the healthcare industry, the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) said they will lift proposed restrictions on the virtual prescription of controlled substances through the end of 2024.
By lifting the proposed restrictions, the DEA is extending flexibilities that allow providers to prescribe controlled medications via telehealth for new patients without previously examining them in person. This is the second extension provided by agencies after the first was slated to end this November.
The extensions follow vehement pushback from healthcare organizations, trade associations, telehealth providers, and...
Today's Sponsors
Today's Sponsor